-+ 0.00%
-+ 0.00%
-+ 0.00%

CAREDX ANNOUNCES CLINICAL VALIDATION RESULTS FOR ALLOHEME™, THE FIRST AI‑POWERED NGS SURVEILLANCE SOLUTION FOR AML AND MDS POST‑CELL THERAPY

Reuters·02/12/2026 12:05:00

Please log in to view news